Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

vaccinessssssssssssssssssss_1

US indicts two Chinese hackers for attempting to steal COVID-19 drug and vaccine research

July 22, 2020 Research and Development COVID-19 Vaccines, coronavirus, hacking, vaccines

Two Chinese hackers have been charged in the US with hacking medical companies and stealing hundreds of millions of dollars …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 22, 2020 Research and Development COVID-19, coronavirus

The COVID-19 news this week once again focuses on vaccines, as the UK has secured early access to 90 million …
News
shutter

Acadia’s pimavanserin falls short at Phase 3 in major depressive disorder

July 21, 2020 Manufacturing and Production, Research and Development Acadia Pharmaceuticals, major depressive disorder, phase 3, trial failure

Acadia Pharmaceuticals has lifted the lid on new Phase 3 for its therapy pimavanserin, revealing that the drug unfortunately failed …
News
512px-oxford_university_colleges-all_souls1

AstraZeneca and Oxford University’s COVID-19 vaccine generates “robust immune responses” in early interim data

July 21, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Oxford University, Vaccine, coronavirus

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …
News

Is Pharma doing enough on sustainability?

July 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antimicrobial resistance, manufacturing, pharma, sustainability

Adoption of sustainable practices in pharmaceutical operations is ticking along, but given the environmental and health risks if this is …
Feature
shutterstock_36423250

Synairgen drug doubles likelihood of recovery in hospitalised COVID-19 patients, early data show

July 20, 2020 Research and Development, Sales and Marketing COVID-19, Synairgen

Respiratory drug firm Synairgen has, like many, been hard at work on a treatment for patients with COVID-19; the company …
News

Innate Pharma announces new Executive Vice President and Chief Medical Officer

July 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Innate Pharma, appointment

Innate Pharma has named Dr Joyson Karakunnel as its new Executive Vice President and Chief Medical Officer (CMO), with current …
Appointment
astrazeneca_sign_sky

AstraZeneca secures accelerated FDA review for Farxiga for for CV death following heart attacks

July 17, 2020 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, fast track

AstraZeneca has made it known that Farxiga (dapagliflozin) has secured Fast Track Designation from the FDA for the reduction of …
News
Doctor online

COVID-19 is pushing healthcare firms to embrace digital transformation, reports suggest

July 16, 2020 Medical Communications, Research and Development digital, healthcare, pharma

The COVID-19 pandemic forced industries across the board to evolve or die with regard to their approach to digital working …
News
janssen_latest_logo_on_sign

Jannsen’s Tremfya becomes first FDA-approved IL-23 inhibitor for active psoriatic arthritis

July 15, 2020 Research and Development, Sales and Marketing FDA, Jannsen, Tremfya, active psoriatic arthritis

Janssen has reported that its therapy Tremfya (guselkumab) has become the first selective interleukin (IL)-23 inhibitor approved by the FDA …
News
xockdown

UK lockdown caused infection ‘R’ rate to drop as low as 0.57, according to a new study

July 15, 2020 Research and Development COVID, COVID-19, Lockdown, coronavirus

A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted. …
News
fdaoutsideweb

FDA committee backs GSK’s belantamab mafodotin in relapsed or refractory multiple myeloma

July 15, 2020 Research and Development, Sales and Marketing Cancer, FDA, GSK, multiple myeloma, pharma

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has moved to recommend the use of GlaxoSmithKline’s belantamab mafodotin, or GSK2857916 as …
News
vaxx

Moderna’s COVID-19 vaccine candidate set for final testing in the US

July 15, 2020 Research and Development COVID-19, coronavirus

The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing. The experimental …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 15, 2020 Research and Development COVID-19, coronavirus, vaccines

The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe …
News
shutter

Malaria prophylactic tafenoquine shows antiviral activity against SARS-CoV-2 in cell cultures

July 14, 2020 Manufacturing and Production, Research and Development 60 Degrees Pharmaceuticals, COVID-19, coronavirus, pharma

Specialist tropical disease drug firm 60 Degrees Pharmaceuticals has revealed that its therapy Arakoda (tafenoquine) has been shown in cell …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026